mda-mb-468 glutathione content

mda-mb-468 glutathione content Mutant p53 reactivators protect breast cancer cells from ferroptosis - Rathnayake - 2024 - Cell Biochemistry and Function MDA-MB-468 Xenograft Model - Altogen

Name: mda-mb-468 glutathione content Mutant p53 reactivators protect breast cancer cells from ferroptosis - Rathnayake - 2024 - Cell Biochemistry and Function MDA-MB-468 Xenograft Model - Altogen
Brand: swgunbroken.com
SKU: 1783585555
Price: 21.93 USD
Availability: InStock
Rating: 4.3384 (14 reviews)

MDA MB 468 Xenograft Model Altogen Labs Disclosing a metabolic signature of cisplatin resistance in MDA MB 231 triple negative breast cancer cells by NMR metabolomics Cancer Cell International Springer Nature Link MDA MB 231, MDA MB 468 and MCF7 cells show different morphologies in Download Scientific Diagram Frontiers Dihydroartemisinin Transferrin Adducts Enhance TRAIL Induced Apoptosis in Triple Negative Breast Cancer in a P53 Independent and ROS Dependent Manner Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports

SKU: 1783585555 · From swgunbroken.com

4.3

USD21.93 USD49.93

Pay in 4 interest-free payments of $5.48 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

Andaloussi, S

Patent Number: 221279

Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance

Franklin, G

Research on MOTS-c in ovariectomized mice (a model for postmenopausal metabolic dysfunction) showed reduced fat accumulation in white adipose tissue, increased brown fat activation, and improved insulin sensitivity after just 5 weeks of treatment